VEGF as a Paracrine Regulator of Conventional Outflow Facility. - Wikidata - awgldk - TriplyDB

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

http://www.wikidata.org/entity/Q37731916

about

Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway.Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration.

P2860

Q43991565-2F835A9B-4D87-4068-8EA4-31A86D2914E4 Q45872509-76BD147E-8623-4624-B81F-EB3129A7DF90 Q50763443-75B68D5D-0685-4A26-87F5-5AC44EAB0249

P2860

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

http://www.wikidata.org/entity/Q37731916

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

@en

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

@nl

type

label

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

@en

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

@nl

prefLabel

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

@en

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

@nl

P1433

Q37731916-E96D6C51-447A-450B-8A58-75BC8FE8EE4B

P1476

Q37731916-B1A26EFA-A18F-4671-8FA5-80A322474C44

P2093

Q37731916-13640B24-2198-4CEE-B0EC-797BC798638E

Q37731916-3307D45C-D41F-4D61-AE71-A1514DAD0CE4

Q37731916-42A106B9-6038-4BF8-A9B9-8411D5B490EA

Q37731916-7EDAB9ED-9808-484D-AACA-FE62213A9917

Q37731916-92D5A9CE-95D6-450B-AD22-40C4DE3976B5

Q37731916-9C0DF08A-7B71-48D4-9437-68C42E727019

Q37731916-AFE48FE7-F917-4FBB-95AC-1ECD40B5BB2A

Q37731916-CAA48253-E5C9-4EDF-BFF1-398D1FA98E2D

Q37731916-E70A1F03-D266-43A1-80F8-B630FCB7D864

P2860

Q37731916-052F4B1C-518E-4BE1-8BD0-047CA97BE239

Q37731916-097878A9-7156-4B9E-BAA2-BC0E30E65F47

Q37731916-0A3E548E-BC4C-422F-A038-9F1BC8DA49E3

Q37731916-0B80806D-2E6C-4DE4-9F07-ECF628A1B7AB

Q37731916-0C021930-A34D-47DA-973F-281392DC1FF0

Q37731916-10AB4C2E-E70B-44B8-9DA4-95536F248DCC

Q37731916-112F1F75-84DA-4D1F-8959-C2DD19B4543A

Q37731916-1B535126-9CEB-41F5-AA8B-2C4602C8A6B4

Q37731916-1D70DD7B-EE0F-4B1E-941E-DF198CBFED25

Q37731916-1E2330C8-A8D4-4184-B5D4-2E46934BDEC8

P304

Q37731916-195CFA3A-2B64-4046-9B0F-34D0B6628D48

P31

Q37731916-CF37AE20-0B9F-4249-BE35-84096C7B33A4

P356

Q37731916-1F0FC3DD-5044-4310-B5BA-210554611743

P407

Q37731916-C7B1A613-9CBF-4C50-BD30-17FFB942EE78

P433

Q37731916-80393BE7-280D-48C3-8F18-BEC2621B8AD7

P478

Q37731916-E821CE77-7985-43EB-A219-47FF99DA6A35

P50

Q37731916-786CBA8E-9D6F-49F6-BEB1-A3A0A078FB57

Q37731916-B8D2B5D2-404B-4913-8907-E30E93381CDF

P577

Q37731916-F5B8B804-4E9E-4C33-BEB1-32D96BADF352

P698

Q37731916-BFAF05AA-D830-43E8-914C-350AD2963BDC

P932

Q37731916-ABDA802B-39AB-489D-B9AB-F9BFD3B3E785

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

VEGF as a Paracrine Regulator of Conventional Outflow Facility.

@en

P2093

Cassandra M Flügel-Koch

http://www.w3.org/2001/XMLSchema#string

Ester Reina-Torres

http://www.w3.org/2001/XMLSchema#string

Guorong Li

http://www.w3.org/2001/XMLSchema#string

Joanne C Wen

http://www.w3.org/2001/XMLSchema#string

Joseph M Sherwood

http://www.w3.org/2001/XMLSchema#string

Katy C Liu

http://www.w3.org/2001/XMLSchema#string

Pratap Challa

http://www.w3.org/2001/XMLSchema#string

R Rand Allingham

http://www.w3.org/2001/XMLSchema#string

W Daniel Stamer

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier

The mouse anterior chamber angle and trabecular meshwork develop without cell death

The biology of VEGF and its receptors

VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin

Schlemm's canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process

The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel

Schlemm's canal endothelia, lymphatic, or blood vasculature?

Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation

Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro

P304

1899-1908

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.16-20779

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Darryl R. Overby

Jason Y H Chang

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28358962

http://www.w3.org/2001/XMLSchema#string

P932

5374885

http://www.w3.org/2001/XMLSchema#string